Table 3.
Metabolites | Circulating acetate | Circulating propionate | Circulating butyrate | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
std ß | P | std β adj | std ß | P | std β adj | std ß | P | std β adj | P | |||
FFA, μmol/L | −0.032 ± 0.084 | 0.701 | 0.003 ± 0.080 | 0.974 | −0.302 ± 0.079 | 0.000 | −0.127 ± 0.078 | 0.103 | −0.381 ± 0.077 | <0.001 | −0.306 ± 0.090 | 0.001 |
TAG, μmol/L | −0.249 ± 0.081 | 0.003 | −0.077 ± 0.081 | 0.340 | −0.225 ± 0.081 | 0.006 | −0.202 ± 0.078 | 0.010 | −0.356 ± 0.078 | <0.001 | −0.137 ± 0.094 | 0.150 |
Glycerol, μmol/L | −0.204 ± 0.082 | 0.014 | −0.190 ± 0.083 | 0.023* | −0.025 ± 0.083 | 0.768 | 0.155 ± 0.081 | 0.059 | −0.286 ± 0.080 | <0.001 | −0.173 ± 0.098 | 0.079 |
Hormones | ||||||||||||
Insulin, mU/L | −0.187 ± 0.079 | 0.019 | 0.003 ± 0.070 | 0.968 | −0.234 ± 0.078 | 0.003 | −0.066 ± 0.068 | 0.336 | −0.406 ± 0.073 | <0.001 | −0.040 ± 0.082 | 0.625 |
GLP-1, pmol/L | 0.402 ± 0.078 | 0.000 | 0.187 ± 0.070 | 0.009 | 0.318 ± 0.080 | 0.000 | 0.218 ± 0.068 | 0.002* | 0.574 ± 0.069 | <0.001 | 0.274 ± 0.081 | 0.001 |
PYY, pmol/L | 0.125 ± 0.097 | 0.201 | 0.107 ± 0.107 | 0.317 | 0.080 ± 0.097 | 0.413 | 0.018 ± 0.105 | 0.868 | 0.182 ± 0.096 | 0.060 | 0.142 ± 0.126 | 0.263 |
Insulin sensitivity | ||||||||||||
M-value, mg/kg/min | −0.224 ± 0.102 | 0.031 | −0.294 ± 0.071 | <0.001 | 0.327 ± 0.099 | 0.001 | 0.161 ± 0.074 | 0.033* | 0.164 ± 0.103 | 0.113 | −0.066 ± 0.091 | 0.469 |
HOMA-IR | −0.247 ± 0.079 | 0.002 | −0.009 ± 0.067 | 0.892 | −0.160 ± 0.080 | 0.047 | 0.007 ± 0.065 | 0.914 | −0.461 ± 0.072 | <0.001 | −0.054 ± 0.078 | 0.494 |
Glucose, mmol/L | −0.228 ± 0.078 | 0.004 | 0.005 ± 0.066 | 0.939 | −0.177 ± 0.078 | 0.025 | −0.044 ± 0.064 | 0.499 | −0.506 ± 0.068 | <0.001 | −0.200 ± 0.075 | <0.001 |
Inflammatory markers | ||||||||||||
LBP, pg/ml | −0.075 ± 0.088 | 0.399 | 0.038 ± 0.087 | 0.667 | −0.262 ± 0.085 | 0.003 | −0.117 ± 0.085 | 0.168 | −0.330 ± 0.083 | <0.001 | −0.116 ± 0.102 | 0.254 |
IL-6, pg/ml | −0.298 ± 0.077 | 0.000 | −0.098 ± 0.070 | 0.163 | −0.177 ± 0.079 | 0.027 | −0.027 ± 0.053 | 0.690 | −0.406 ± 0.073 | 0.000 | −0.021 ± 0.082 | 0.803 |
IL-8, pg/ml | −0.079 ± 0.080 | 0.324 | 0.024 ± 0.086 | 0.778 | 0.126 ± 0.079 | 0.113 | 0.164 ± 0.084 | 0.051 | −0.023 ± 0.080 | 0.775 | 0.185 ± 0.100 | 0.067 |
TNF-α, pg/ml | −0.296 ± 0.076 | 0.000 | −0.105 ± 0.076 | 0.168 | −0.095 ± 0.079 | 0.232 | −0.048 ± 0.075 | 0.523 | −0.330 ± 0.075 | <0.001 | −0.047 ± 0.089 | 0.598 |
Substrate Oxidation | ||||||||||||
Fat, E% | −0.156 ± 0.084 | 0.065 | −0.021 ± 0.086 | 0.812 | −0.117 ± 0.084 | 0.167 | −0.052 ± 0.085 | 0.543 | −0.317 ± 0.080 | <0.001 | −0.138 ± 0.101 | 0.172 |
CHO, E % | 0.074 ± 0.087 | 0.396 | 0.159 ± 0.094 | 0.094 | −0.092 ± 0.087 | 0.291 | −0.167 ± 0.092 | 0.072 | 0.002 ± 0.087 | 0.986 | 0.047 ± 0.111 | 0.672 |
β, standardized β coefficient + standard error of coefficient of fasting circulating acetate, propionate and butyrate as dependent variable in a simple regression and multiple regression analysis adjusted for age, sex and BMI. M-value (n = 93), PYY (n = 107). Adj, adjusted, std standardized, E%, percentage of energy expenditure, FFA, free fatty acids, TAG, triglycerides, GLP-1, glucagon-like peptide 1, PYY, peptide YY, HOMA-IR, homeostatic model assessment of insulin resistance, LBP, lipopolysaccharide binding protein, IL-6, interleukin 6, IL-8, interleukin 8, TNFα, tumour necrosis factor alpha.